Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the international Breast Cancer Study Group (IBCSG) trial VI

Author： Pagani O.   O'Neill A.   Castiglione M.   Gelber R.D.   Goldhirsch A.   Rudenstam C.-M.   Lindtner J.   Collins J.   Crivellari D.   Coates A.   Cavalli F.   Thurlimann B.   Simoncini E.   Fey M.   Price K.   Senn H.-J.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.34, Iss.5, 1998-04, pp. : 632-640

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients - effect of adjuvant chemotherapy

By Poikonen P.   Saarto T.   Elomaa I.   Joensuu H.   Blomqvist C.  

European Journal of Cancer, Vol. 36, Iss. 1, 2000-01 ,pp. : 43-48

Elsevier

Access to resources Recommend Favorite

Chemotherapy versus hormonal adjuvant treatment in premenopausal patients with breast cancer

By Jakesz R.   Hausmaninger H.   Samonigg H.  

European Journal of Cancer, Vol. 38, Iss. 3, 2002-01 ,pp. : 327-332

Elsevier

Access to resources Recommend Favorite

Is axillary clearance the standard of care for breast cancer patients with sentinel node involvement?

By Fentiman Ian S  

Future Oncology, Vol. 2, Iss. 5, 2006-10 ,pp. : 621-626

Future Medicine

Access to resources Recommend Favorite

The clinical significance of axillary sentinel lymph node biopsy in different clinical stages breast cancer patients after neoadjuvant chemotherapy

By Xu Juan   Wu Xinhong   Feng Yaojun   Yuan Feng   Fan Wei  

The Chinese-German Journal of Clinical Oncology, Vol. 12, Iss. 11, 2013-11 ,pp. : 521-523

Springer Publishing Company

Access to resources Recommend Favorite

Postoperative Adjuvant Randomised Trial Comparing Chemoendocrine Therapy, Chemotherapy and Immunotherapy for Patients with Stage II Breast Cancer: 5-year Results from The Nishinihon Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC) of Japan

By Morimoto T.   Ogawa M.   Orita K.   Sugimachi K.   Toge T.   Dohi K.   Nomura Y.   Monden Y.   Ogawa N.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 235-242

Elsevier

Access to resources Recommend Favorite